Juniper Pharma (NASDAQ: JNP) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $7.8 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.